Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Immunogenicity and Safety of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine in Children in Sri Lanka

NCT00463684 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT00463684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00463684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Immunogenicity and Safety of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine in Children in Sri Lanka
Lead sponsor
PATH
Phase
Phase 4
Overall status
Completed
Start date
July 7, 2007
Completion date
October 6, 2008
Enrollment
278 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis